Permanently Discontinued

CLINDAMYCIN INJECTION IN 5% DEXTROSE

BAXTER CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CLINDAMYCIN INJECTION IN 5% DEXTROSE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CLINDAMYCIN INJECTION IN 5% DEXTROSE 300MG has been permanently discontinued (last updated April 2, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CLINDAMYCIN INJECTION IN 5% DEXTROSE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength300MG

Last updated2023-04-02

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

RATIO-CLINDAMYCIN CAPSULES - 300MG

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

300MG · DIN 02192659

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DALACIN C PHOSPHATE

PFIZER CANADA ULC

150MG · DIN 00260436

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

CLINDAMYCIN INJECTION, USP

ABBOTT LABORATORIES, LIMITED

150MG · DIN 02130866

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

CLINDAMYCIN INJECTION USP

SANDOZ CANADA INCORPORATED

150MG · DIN 02230540

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

DALACIN C FLAVOURED GRANULES

PFIZER CANADA ULC

75MG · DIN 00225851

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DALACIN C 150 MG

PFIZER CANADA ULC

150MG · DIN 00030570

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02485451

Strength

300MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

CLINDAMYCIN

See all CLINDAMYCIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2023-04-02

Permanently Discontinued

Business reasons

Other Products from BAXTER CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP

DIN 00438014

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786292

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP

DIN 00438049

(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786209

(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP

DIN 00437999

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786217